Altimmune, Inc.
ALT
$3.42
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.36M | -19.01M | -22.15M | -19.58M | -23.18M |
| Total Depreciation and Amortization | 26.00K | 27.00K | 30.00K | 29.00K | 33.00K |
| Total Amortization of Deferred Charges | -171.00K | 113.00K | 58.00K | -- | -- |
| Total Other Non-Cash Items | 4.44M | 3.44M | 2.50M | 3.31M | 2.42M |
| Change in Net Operating Assets | 3.62M | 3.53M | 209.00K | -608.00K | 2.46M |
| Cash from Operations | -19.45M | -11.90M | -19.35M | -16.84M | -18.27M |
| Capital Expenditure | -1.00K | 0.00 | -10.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -79.16M | -149.32M | 101.12M | -5.10M | 13.63M |
| Cash from Investing | -79.16M | -149.32M | 101.11M | -5.10M | 13.63M |
| Total Debt Issued | 20.00M | 0.00 | 15.00M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 61.65M | 39.67M | 37.83M | 34.92M | 10.09M |
| Repurchase of Common Stock | -25.00K | 0.00 | -6.00K | -678.00K | -2.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -490.00K | -322.00K | -577.00K | -125.00K | -- |
| Cash from Financing | 81.13M | 39.35M | 52.24M | 34.12M | 10.09M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.48M | -121.87M | 134.00M | 12.18M | 5.45M |